SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001178913-24-000365
Filing Date
2024-02-05
Accepted
2024-02-05 09:15:02
Documents
1
Group Members
SPHERA GLOBAL HEALTHCARE GP LTDSPHERA GLOBAL HEALTHCARE MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk2430880.htm SC 13G/A 87263
  Complete submission text file 0001178913-24-000365.txt   89073
Mailing Address 4 ITZHAK SADE BUILDING A 29TH FLOOR TEL AVIV L3 6777520
Business Address 4 ITZHAK SADE BUILDING A 29TH FLOOR TEL AVIV L3 6777520 972-3-6845535
SPHERA FUNDS MANAGEMENT LTD. (Filed by) CIK: 0001496201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13G/A

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Subject) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91228 | Film No.: 24594240
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)